65% were on insulin.11% insulin and non-insulin agents.19% sulphonylurea +/- other non-insulin agents.4% non-sulphonylurea, non-insulin agents.Insulin therapy highlighted as a risk factor for recurrent hypoglycaemia among T2DM.Age and predisposing co-morbidities identified as predictors of increased long-term mortality.Three hypoglycaemic related deaths during follow-up. The gene discussed is INS; the disease is Hypoglycemia.